Odyssey Health (ODYY) Assets (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 402.22% |
| Oct 31, 2025 | 188.84% |
| Jul 31, 2025 | -69.77% |
| Apr 30, 2025 | -38.36% |
| Jan 31, 2025 | -21.75% |
| Oct 31, 2024 | -41.82% |
| Jul 31, 2024 | -95.68% |
| Apr 30, 2024 | -3.37% |
| Jan 31, 2024 | 2,195.59% |
| Oct 31, 2023 | 34.28% |
| Jul 31, 2023 | 4.56% |
| Apr 30, 2023 | -5.94% |
| Jan 31, 2023 | -46.59% |
| Oct 31, 2022 | 52.32% |
| Jul 31, 2022 | -7.98% |
| Apr 30, 2022 | 85.24% |
| Jan 31, 2022 | -64.13% |
| Oct 31, 2021 | 52.62% |
| Jul 31, 2021 | -58.00% |
| Apr 30, 2021 | 947.68% |
| Jan 31, 2021 | -65.19% |
| Oct 31, 2020 | 277.50% |
| Jul 31, 2020 | -62.18% |
| Apr 30, 2020 | -9.70% |
| Jan 31, 2020 | -8.01% |
| Oct 31, 2019 | -37.36% |
| Jul 31, 2019 | 2,005.11% |
| Apr 30, 2019 | 13.65% |
| Jan 31, 2019 | -11.85% |
| Oct 31, 2018 | -7.37% |
| Jul 31, 2018 | -23.40% |
| Apr 30, 2018 | 1,204.55% |
| Jan 31, 2018 | -98.46% |
| Oct 31, 2017 | 11.74% |
| Jul 31, 2017 | 83.11% |
| Apr 30, 2017 | 16.17% |
| Jan 31, 2017 | 30.90% |
| Oct 31, 2016 | -16.39% |
| Jul 31, 2016 | -19.46% |
| Apr 30, 2016 | 5,365.32% |
| Jan 31, 2016 | -73.17% |
| Oct 31, 2015 | 8.28% |